AIDS

The agency is seeking grant applications for projects using genomics to study HIV/AIDS drug responses and comorbidities.

The method simplifies previous techniques, and preliminary testing using a microfluidic device indicates it could ultimately be used in low-resource settings.

This Week in Science

In Science this week: reason for partial HIV vaccine protection, and more.

The fully automated self-confirming assay will simultaneously detect HIV/AIDS antibodies and viral RNA in a single specimen.

Shipping of the assay, Cepheid's eighth product release in 2014, is anticipated to begin in February 2015.

Two new studies demonstrate improved methods using droplet digital PCR to detect very low viral loads in HIV-positive patients, pushing the detection threshold lower than that of real-time PCR.

NEW YORK (GenomeWeb) – Roche today announced the launch of the Global Access Program for HIV viral load testing.

NEW YORK (GenomeWeb) – University Hospital Case Medical Center today said it has reached a deal with Arup Laboratories to offer a sequencing-based HIV diagnostic test.

NEW YORK (GenomeWeb) – Diaxonhit today said that Bpifrance has granted it more than €1.7 million ($2.4 million) to develop a companion diagnostic for an AIDS vaccine under development.

NEW YORK (GenomeWeb News) – The University of Washington has reeled in a $15 million contract from the National Institute of Allergy and Infectious Diseases to create a genomics core that will be a national resource of nonhuman primate genomes and support research into AIDS vaccines.

Pages

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.